OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines
Ida Paciello, Giuseppe Maccari, Giulio Pierleoni, et al.
Science Immunology (2024) Vol. 9, Iss. 98
Open Access | Times Cited: 7
Ida Paciello, Giuseppe Maccari, Giulio Pierleoni, et al.
Science Immunology (2024) Vol. 9, Iss. 98
Open Access | Times Cited: 7
Showing 7 citing articles:
Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2
Hengrui Hu, Chengcheng Leng, Yanni Shu, et al.
Journal of Virology (2025)
Open Access
Hengrui Hu, Chengcheng Leng, Yanni Shu, et al.
Journal of Virology (2025)
Open Access
Enabling the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants including KP.2
Chao Su, Juanhua He, Yufeng Xie, et al.
hLife (2025)
Open Access
Chao Su, Juanhua He, Yufeng Xie, et al.
hLife (2025)
Open Access
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering
Yunji Liao, Hang Ma, Zhenyu Wang, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
Yunji Liao, Hang Ma, Zhenyu Wang, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
Screened Fv-Antibodies against the Angiotensin-Converting Enzyme 2 (ACE2) Receptor Neutralizing the Infection of SARS-CoV-2
Jaeyong Jung, Soonil Kwon, Jeong Soo Sung, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3914-3920
Closed Access
Jaeyong Jung, Soonil Kwon, Jeong Soo Sung, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3914-3920
Closed Access
Macromolecular interaction mechanism of the bacteriocin EntDD14 with the receptor binding domain (RBD) for the inhibition of SARS-CoV-2 and the JN.1 variant: Biomedical study based on elastic networks, stochastic Markov models, and macromolecular volumetric analysis
Luis Moncayo-Molina, María Erlinda Aguaiza Pichazaca, José Suárez Padilla, et al.
Biophysical Chemistry (2024) Vol. 318, pp. 107388-107388
Closed Access
Luis Moncayo-Molina, María Erlinda Aguaiza Pichazaca, José Suárez Padilla, et al.
Biophysical Chemistry (2024) Vol. 318, pp. 107388-107388
Closed Access
Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants
Fanglei Zuo, Yunlong Cao, Rui Sun, et al.
Journal of Virology (2024)
Closed Access
Fanglei Zuo, Yunlong Cao, Rui Sun, et al.
Journal of Virology (2024)
Closed Access
Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein
Sameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
